|
|
|
Name
|
Delcath Systems Inc. |
|
Address:
|
1100 Summer St.
|
|
City:
|
Stamford
|
|
State:
|
CT
|
|
Zip:
|
06905
|
|
Phone
|
203-323-8668
|
|
Web
Site:
|
www.delcath.com
|
|
Fax:
|
203-961-0120
|
|
No. Employees
|
5
|
|
No. Researchers
|
0
research done byparticipating doctors in field who forward their data/results
|
|
Capitalization
|
$36,120,000
|
|
R&D Spending
|
$1,600,000
|
|
Major Investors
|
N/A
|
|
Strategic Alliances
|
N/A
|
|
Products
|
Delivering chemotherapy agents
|
|
CFO
|
Paul Feinstein
|
|
Chief Scientific Research Officer
|
Samuel Herschkowitz
|
|
Ownership
|
Public (NASDAQ:DCTH)
|
|
CEO
|
M.S. Koly
|
|
Year Founded
|
1988
|
|
President
|
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
N/A
|
|
|
